 Anti-microbial resistance, AMR, is a growing problem worldwide, leading to increased morbidity and mortality from infectious diseases. One of the most concerning types of AMR is that caused by extended spectrum beta-lactamase, ESBL, or carbapenamase-producing enterobacterial CPEs. These bacteria are resistant to many commonly used antibiotics and are associated with high mortality rates. The gut microbiota plays a key role in the spread of AMR, as it serves as a reservoir for antibiotic resistance genes. Strategies to manipulate the gut microbiota to reduce colonization with AMR bacteria, such as dietary changes, probiotics, phage therapy, and fecal microbiota transplantation, FMT, may help to reduce the spread of AMR. This article was authored by Blair Merrick, Chrissy Sergaki, Lindsay Edwards, and others.